IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
Launched by ACCELERATED CURE PROJECT FOR MULTIPLE SCLEROSIS · Jun 29, 2015
Trial Information
Current as of June 13, 2025
Recruiting
Keywords
ClinConnect Summary
The iConquerMS™ study is a unique research project created by and for individuals living with multiple sclerosis (MS). This initiative invites people with MS to share their health information and experiences, which will help researchers better understand the condition and speed up the development of new treatments. The study is currently looking for participants who are 21 years or older and willing to provide informed consent, meaning they understand the study and agree to take part.
If you choose to participate, you'll be part of a community working together to improve MS research. You can expect to contribute your insights and health data, which may help shape future studies and treatments for MS. This is a chance to make a difference not just for yourself, but for others living with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 21 years of age or older at the time of informed consent or under 21 with parental consent and participant assent.
- Exclusion Criteria:
- • Unwilling or unable to provide informed consent.
About Accelerated Cure Project For Multiple Sclerosis
The Accelerated Cure Project for Multiple Sclerosis (ACP) is a leading nonprofit organization dedicated to advancing research and improving the lives of those affected by multiple sclerosis (MS). By fostering collaboration among researchers, clinicians, and patients, ACP aims to accelerate the development of effective treatments and ultimately find a cure for MS. The organization emphasizes data sharing, innovative research initiatives, and the integration of diverse perspectives to enhance understanding of the disease. Through its commitment to transparency and scientific rigor, the Accelerated Cure Project seeks to transform the landscape of MS research and care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Waltham, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials